Vaccines based on inactivated SARS-CoV-2 virus are commonly used in developing countries due to their low cost. New research from Karolinska Institutet in Sweden shows that a booster shot of mRNA vaccine to individuals who have received two doses of inactivated vaccine offers the same level of protection against COVID-19 as three doses of mRNA vaccine. The findings are published in the journal Nature Communications.
mRNA booster vaccines may be a good investment in developing countries
-
Featured HeadlinesBeyond a technical bug: Biased algorithms and moderation are censoring activists on social media
-
Featured HeadlinesGovernment agencies are tapping a facial recognition company to prove you’re you – here’s why that raises concerns about privacy, accuracy and fairness
-
Featured HeadlinesTech giants need to step up to help close Canada’s digital divide
-
ComputersDaemons are the programs that run the internet. Here’s why it’s important to understand them.
-
AppsResearchers develop automated approach to extract security policies from software
-
AppsSafety app for drivers debuts in flood-plagued Virginia city
